Join the collaboration

A demo is available online to experience the MCDA Value matrix. It is being used in a number of workshops and data is being collected to explore functionality and variation among participants.

Combined results from demonstrator workshops

Workshop participants were asked to weight components of the MCDA Value Matrix and to assess the intrinsic value of intervention Y indicated for disease X using defined scales and synthesized data prepared using the EVIDEM™ methodology. Participants have included policy and formulary decisionmakers, physicians, pharmacists, nurses, health economists/epidemiologists, other researchers, other healthcare professionals, and others not specified.

Collected weights and scores are reported below.

  
[+ Click to enlarge]

Scores and normalized weights were combined using a MCDA linear model to estimate the value of the intervention; contribution of each component of the MCDA Value Matrix to the value estimate is reported below.

[+ Click to enlarge]

The value estimate is a comprehensive measure of relative value (i.e., comparative efficacy, safety, patient reported outcomes, impact on drug and other spending, cost-effectiveness) as well as absolute value (i.e., severity of disease, size of population affected, types of benefit at population and patient level, quality of evidence) while taking into consideration clinical guidelines and limitations of alternative interventions.

[+ Click to enlarge]

Most importantly, through the framework structure, it provides a transparent link to how components of decision are considered and on which evidence those considerations are based.